Knowing which kind of psoriasis you have helps you and your doctor make a treatment plan. Most people have only one type at a time. Experts believe psoriasis is an autoimmune disease.

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Women with psoriasis had increased risks for preeclampsia/eclampsia and cardiac arrhythmias during delivery hospitalizations, according to a real-world study evaluating maternal cardiovascular ...

Jan. 20, 2025 — People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut', according to new research.

More information: Patrik Lundquist et al, Mild-to-moderate psoriasis is associated with subclinical inflammation in the ...

The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...

Based on this information, in addition to its many positive reviews ... standard" of dandruff shampoos and their new formula ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

Patients with psoriasis show a 50% increased risk of developing Sjögren’s syndrome (SS), with higher risk in those with psoriatic arthritis or on biological treatments. Shared pathogenic ...